The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Open accessPublished version of a preprint
Abstract
Interleukin-11 is important for lung fibroblast activation in idiopathic pulmonary fibrosis, and its signaling represents a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-11 is a key driver of myofibroblast activation and differentiation in IPF41”
From Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study (2026) · cites this paper as [41]
In the citing paper
“Microbiota driven intestinal fibrosis may be mediated by induction of the IL-33 receptor ST2 on epithelial cells157 or the pro-fibrotic action of tumor necrosis factor-like cytokine 1A (TL1A)158”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [158]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Bootstrap Methods and their Application
Davison, A. C., & Hinkley, D. V. (1997) · doi:10.1017/cbo9780511802843 · Cited by 7,350
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654 · cited 2×
“Antifibrotic small-molecule drugs such as nintedanib (5) and pirfenidone (6) are approved for the treatment of IPF but have notable toxicities (2).”
BackgroundMethodSelf-citationMapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Durinck, S., Spellman, P. T., Birney, E., & Huber, W. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,156
Flagged first, then by citations
Cited by
Sorted by citations
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
Current treatment paradigms and emerging therapies for NAFLD/NASH
Raza, S. (2020) · Frontiers in bioscience · doi:10.2741/4892 · Cited by 329
TGF ‐β as a driver of fibrosis: physiological roles and therapeutic opportunities
Budi, E. H., Schaub, J. R., Decaris, M. L., Turner, S., & Derynck, R. (2021) · The Journal of Pathology · doi:10.1002/path.5680 · Cited by 310
Contributions of alveolar epithelial cell quality control to pulmonary fibrosis
Katzen, J. B., & Beers, M. F. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139519 · Cited by 300
Widjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 279
Self-citationImmune Cells and Immunotherapy for Cardiac Injury and Repair
Rurik, J. G., Aghajanian, H. K., & Epstein, J. A. (2021) · Circulation Research · doi:10.1161/circresaha.121.318005 · Cited by 273
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Montero, P., Milara, J., Roger, I., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126211 · Cited by 263
The mesenchymal context in inflammation, immunity and cancer
Koliaraki, V., Prados, A., Armaka, M., & Kollias, G. A. (2020) · Nature Immunology · doi:10.1038/s41590-020-0741-2 · Cited by 252
Fibroblast pathology in inflammatory diseases
Wei, K., Nguyen, H. N., & Brenner, M. B. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149538 · Cited by 249
Role of interleukins in the pathogenesis of pulmonary fibrosis
She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 231
TGF‑β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)
Ye, Z., & Hu, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4965 · Cited by 226
COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219
Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments
Tang, X., Li, P., & Chen, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00280 · Cited by 223
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Sweeney, M., Corden, B., & Cook, S. A. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910865 · Cited by 201
Self-citationBai, X., Zhao, G., Chen, Q., Li, Z., Gao, M., Ho, W., Xu, X., & Zhang, X. (2022) · Science Advances · doi:10.1126/sciadv.abn7162 · Cited by 195
Cook, S. A., & Schäfer, S. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-041818-011649 · Cited by 178
Self-citationBhattacharya, M., & Ramachandran, P. (2023) · Nature Immunology · doi:10.1038/s41590-023-01551-9 · Cited by 148
Dong, J., Viswanathan, S., Adami, E., Singh, B. K., Chothani, S. P., Ng, B., Lim, W., Zhou, J., Tripathi, M., Ko, N. S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20303-z · Cited by 125
Self-citationIdiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches
Glass, D. S., Grossfeld, D. J., Renna, H. A., Agarwala, P., Spiegler, P. A., Kasselman, L. J., Glass, A. D., DeLeon, J. R., & Reiss, A. B. (2020) · Respiratory Investigation · doi:10.1016/j.resinv.2020.04.002 · Cited by 129
Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines
West, N. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01093 · Cited by 125
Han, D., Gong, H., Wei, Y., Xu, Y., Zhou, X., Wang, Z., & Feng, F. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154680 · Cited by 118
Jasso, G. J., Jaiswal, A., Varma, M., Laszewski, T., Grauel, A. L., Omar, A. S., Silva, N., Dranoff, G., Porter, J. A., Mansfield, K. G., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001532 · Cited by 114
Metcalfe, R. D., Putoczki, T. L., & Griffin, M. D. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01424 · Cited by 116
Emerging roles for IL-11 in inflammatory diseases
Fung, K. Y., Louis, C., Metcalfe, R. D., Kosasih, C. C., Wicks, I. P., Griffin, M. D. W., & Putoczki, T. L. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155750 · Cited by 104
Ng, B., Cook, S. A., & Schäfer, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00531-5 · Cited by 98
Self-citationSeyedsadr, M., Wang, Y., Elzoheiry, M., Gopal, S. S., Jang, S., Duran, G., Chervoneva, I., Kasimoglu, E., Wrobel, J. A., Hwang, D., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221007120 · Cited by 92
Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside
Ghonim, M. A., Boyd, D. F., Flerlage, T., & Thomas, P. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170499 · Cited by 90
Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?
Zapater, E. O., Signes‐Costa, J., Montero, P., & Roger, I. (2022) · Biomedicines · doi:10.3390/biomedicines10061423 · Cited by 85
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 92
IL‐11 in cardiac and renal fibrosis: Late to the party but a central player
Corden, B., Adami, E., Sweeney, M. D., Schäfer, S., & Cook, S. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15013 · Cited by 83
Self-citationWidjaja, A. A., Dong, J., Adami, E., Viswanathan, S., Ng, B., Pakkiri, L. S., Chothani, S. P., Singh, B. K., Lim, W., Zhou, J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba8146 · Cited by 82
Self-citationTowards precision medicine in heart failure
Weldy, C. S., & Ashley, E. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00566-9 · Cited by 81
Allanki, S., Strilić, B., Scheinberger, L., Onderwater, Y. L., Marks, A., Günther, S., Preussner, J., Kikhi, K., Looso, M., Stainier, D. Y. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg6497 · Cited by 82
Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart
Umbarkar, P., Tousif, S., Singh, A. P., Anderson, J. C., Zhang, Q., Tallquist, M. D., Woodgett, J. R., & Lal, H. (2022) · Circulation Research · doi:10.1161/circresaha.122.321431 · Cited by 83
Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
van Geffen, C., Deißler, A., Quante, M., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663203 · Cited by 82
TGF-β and RAS jointly unmask primed enhancers to drive metastasis
Lee, J. H., Rivera, F. J. S., He, L. Y., Basnet, H., Chen, F., Spina, E., Li, L., Torner, C., Chan, J. E., Yarlagadda, D. V. K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.014 · Cited by 81
Regulation of the alveolar regenerative niche by amphiregulin-producing regulatory T cells
Kaiser, K. A., Loffredo, L. F., Santos-Alexis, K. D. L., Ringham, O. R., & Arpaia, N. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20221462 · Cited by 79
Vascular dysfunction in aged mice contributes to persistent lung fibrosis
Caporarello, N., Meridew, J. A., Aravamudhan, A., Jones, D. L., Austin, S. A., Pham, T. X., Haak, A. J., Choi, K. M., Tan, Q., Haresi, A. J., et al. (2020) · Aging Cell · doi:10.1111/acel.13196 · Cited by 79
Widjaja, A. A., Viswanathan, S., Shekeran, S. G., Adami, E., Lim, W., Chothani, S. P., Tan, J., Goh, J. W. T., Chen, H., Lim, S. Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35306-1 · Cited by 79
Self-citationLim, W., Ng, B., Widjaja, A. A., Xie, C., Su, L., Ko, N. S. J., Lim, S.-Y., Kwek, X.-Y., Lim, S., Cook, S. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227505 · Cited by 78
Self-citationMultiplatform Single-Cell Analysis Identifies Immune Cell Types Enhanced in Pulmonary Fibrosis
Serezani, A. P. M., Pascoalino, B. D., Bazzano, J. M. R., Vowell, K. N., Tanjore, H., Taylor, C. J., Calvi, C. L., McCall, A. S., Bacchetta, M. D., Shaver, C. M., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0418oc · Cited by 78
Distinctive role of inflammation in tissue repair and regeneration
Choi, B., Lee, C., & Yu, J. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01428-3 · Cited by 77
Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling
Chen, Y., Wang, L., Huang, S., Ke, J.-F., Wang, Q., Zhou, Z., & Chang, W. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102020 · Cited by 73
Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis
Nanri, Y., Nunomura, S., Terasaki, Y., Yoshihara, T., Hirano, Y., Yokosaki, Y., Yamaguchi, Y., Feghali‐Bostwick, C. A., Ajito, K., Murakami, S., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0245oc · Cited by 72
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
Roger, I., Milara, J., Montero, P., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094980 · Cited by 74
Działo, E., Czepiel, M., Tkacz, K., Siedlar, M., Kania, G., & Błyszczuk, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810072 · Cited by 72
Fibroblast‐specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease
Ng, B., Dong, J., Viswanathan, S., Widjaja, A. A., Paleja, B. S., Adami, E., Ko, N. S. J., Wang, M., Lim, S., Tan, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001045rr · Cited by 69
Self-citationUnderstanding interleukin 11 as a disease gene and therapeutic target
Cook, S. A. (2023) · Biochemical Journal · doi:10.1042/bcj20220160 · Cited by 70
Self-citationAdami, E., Viswanathan, S., Widjaja, A. A., Ng, B., Chothani, S. P., Tham, N., Tan, J., Lio, P. M., George, B. L., Altunoğlu, U., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab168 · Cited by 67
Self-citationIL-6 family cytokines in respiratory health and disease
Dawson, R., Jenkins, B. J., & Saad, M. I. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155520 · Cited by 66
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
Kim, Y., Yang, H.-I., & Kim, K. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914509 · Cited by 69
Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization
Rui, Y., Han, X., Jiang, A., Hu, J., Li, M., Liu, B., Qian, F., & Huang, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175184 · Cited by 61
Lim, W., Corden, B., Ng, B., Vanezis, K., D’Agostino, G. A., Widjaja, A. A., Song, W., Xie, C., Su, L., Kwek, X.-Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74944-7 · Cited by 60
Self-citationZhou, J., Chen, H., Wang, Q., Chen, S., Wang, R., Wang, Z., Yang, C., Chen, A., Zhao, J., Zhou, Z., et al. (2022) · Aging Cell · doi:10.1111/acel.13680 · Cited by 59
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Branco, F., Cunha, J., Mendes, M., Vitorino, C., & Sousa, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c01790 · Cited by 60
Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis
Tikhomirov, R., Reilly-O’Donnell, B., Catapano, F., Faggian, G. G., Gorelik, J., Martelli, F., & Emanueli, C. (2020) · Cells · doi:10.3390/cells9030592 · Cited by 56
Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy
Widjaja, A. A., Chothani, S. P., & Cook, S. A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1761203 · Cited by 55
Self-citationEngrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation
Györfi, A., Matei, A., Fuchs, M., Liang, C., Rigau, A. R., Hong, X., Zhu, H., Luber, M., Bergmann, C., Dees, C., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201916 · Cited by 56
Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis
Xu, S., Yang, X., Chen, Q., Liu, Z., Chen, Y., Yao, X., Xiao, A., Tian, J., Xie, L., Zhou, M., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104312 · Cited by 53
Dong, S., Fang, H., Zhu, J., Wu, Z., Liu, Y., Zhu, J., Ma, B., Chen, Q., & Yang, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c15130 · Cited by 51
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
Ma, H., Liu, S., Li, S., & Xia, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.918771 · Cited by 54
Widjaja, A. A., Shekeran, S. G., Adami, E., Ting, J. G. W., Tan, J., Viswanathan, S., Lim, S. Y., Tan, P. H., Hübner, N., Coffman, T. M., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021040577 · Cited by 50
Self-citationCellular and Molecular Mechanisms of Intestinal Fibrosis
Wu, X., Lin, X., Tan, J., Liu, Z., He, J., Hu, F., Wang, Y., Chen, M., Liu, F., & Mao, R. (2023) · Gut and Liver · doi:10.5009/gnl220045 · Cited by 53
Self-citationNovel inhalation therapy in pulmonary fibrosis: principles, applications and prospects
Zheng, M., Zhu, W., Gao, F., Zhuo, Y., Mo, Z., Wu, G., & Feng, C. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02407-6 · Cited by 53
Huang, X., Gu, S., Liu, C., Zhang, L., Zhang, Z., Zhao, Y., Khoong, Y., Li, H., Gao, Y., Liu, Y., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.07.181 · Cited by 49
Skuratovskaia, D., Komar, A., Vulf, M. A., Quang, H. V., Shunkin, E. O., Volkova, L. V., Газатова, Н. Д., Затолокин, П. А., & Litvinova, L. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041774 · Cited by 48
Host IL11 Signaling Suppresses CD4+ T cell–Mediated Antitumor Responses to Colon Cancer in Mice
Huynh, J., Baloyan, D., Chisanga, D., Shi, W., O'Brien, M., Afshar‐Sterle, S., Alorro, M., Pang, L., Williams, D. S., Parslow, A. C., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-1023 · Cited by 48
Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis
Velagacherla, V., Mehta, C. H., Nayak, Y., & Nayak, U. Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120283 · Cited by 48
Interleukin-6–dependent epithelial fluidization initiates fibrotic lung remodeling
Stancil, I. T., Michalski, J. E., Hennessy, C. E., Hatakka, K. L., Yang, I. V., Kurche, J. S., Rincón, M., & Schwartz, D. A. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo5254 · Cited by 46
Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 49
Ng, B., Widjaja, A. A., Viswanathan, S., Dong, J., Chothani, S. P., Lim, S., Shekeran, S. G., Tan, J., McGregor, N. E., Walker, E. C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93623-9 · Cited by 46
Self-citationUnraveling the molecular architecture of autoimmune thyroid diseases at spatial resolution
Martínez‐Hernández, R., de la Blanca, N. S., Sacristan-Gomez, P., Serrano-Somavilla, A., de Nova, J. L. M., Sánchez‐Cabo, F., Heyn, H., Sampedro-Nuñez, M. A., & Marazuela, M. (2024) · Nature Communications · doi:10.1038/s41467-024-50192-5 · Cited by 45
Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome
Lim, W., Dong, J., Ng, B., Widjaja, A. A., Xie, C., Su, L., Kwek, X.-Y., Tee, N., Pua, C. J., Schäfer, S., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.320381 · Cited by 45
Self-citationInterleukin-11 drives human and mouse alcohol-related liver disease
Effenberger, M., Widjaja, A. A., Grabherr, F., Schaefer, B., Grander, C., Mayr, L., Schwärzler, J., Enrich, B., Moser, P. L., Fink, J., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326076 · Cited by 44
Self-citationThe cytokine interleukin-11 crucially links bone formation, remodeling and resorption
Kespohl, B., Schumertl, T., Bertrand, J., Lokau, J., & Garbers, C. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.04.002 · Cited by 42
Interleukin 11 (IL-11): Role(s) in Breast Cancer Bone Metastases
Maroni, P., Bendinelli, P., Ferraretto, A., & Lombardi, G. (2021) · Biomedicines · doi:10.3390/biomedicines9060659 · Cited by 39
Wang, L., Zhu, T., Feng, D., Li, R., & Zhang, C. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500434 · Cited by 41
Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy
Allam, A. H., Yakou, M. H., Pang, L., Ernst, M., & Huynh, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767939 · Cited by 38
Gerckens, M., Schorpp, K., Pelizza, F., Wögrath, M., Reichau, K., Ma, H., Dworsky, A.-M., Sengupta, A., Stoleriu, M. G., Heinzelmann, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb3673 · Cited by 39
Metcalfe, R. D., Hanssen, E. G., Fung, K. Y., Aizel, K., Kosasih, C. C., Zlatic, C. O., Doughty, L., Morton, C. J., Leis, A. P., Parker, M. W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42754-w · Cited by 37
CB 1 R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome
Çınar, R., Park, J. K., Zawatsky, C. N., Coffey, N. J., Bodine, S. P., Abdalla, J., Yokoyama, T., Jourdan, T., Jay, L., Zuo, M. X. G., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.471 · Cited by 35
The role of proteolysis in interleukin-11 signaling
Lokau, J., Kespohl, B., Kirschke, S., & Garbers, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119135 · Cited by 35
Li, Y., Luo, C., Zeng, Y., Zheng, Z., Tao, D., Liu, Q., Hong, Y., Wang, S., Long, H., & Xu, Z. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.07.005 · Cited by 34
Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics
Chen, T., Zhang, Z., Weng, D., Lu, L., Wang, X., Xing, M., Qiu, H., Zhao, M., Shen, L., Zhou, Y., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.013 · Cited by 34
Wu, P., Lin, B., Huang, S., Meng, J., Zhang, F., Zhou, M., Hei, X., Yu, K., Yang, H., & Huang, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.846106 · Cited by 34
HER2 drives lung fibrosis by activating a metastatic cancer signature in invasive lung fibroblasts
Liu, X., Geng, Y., Liang, J., Coelho, A. L., Yao, C., Deng, N., Wang, Y., Dai, K., Huang, G., Xie, T., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220126 · Cited by 34
Self-citationLazăr, M., Săndulescu, M., Barbu, E. C., Chițu, C. E., Andreescu, D. I., Anton, A. N., Erculescu, T. M., Petre, A. M., Duca, G. T., Simion, V., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12030639 · Cited by 35
Inhalable myofibroblast targeting nanoparticles for synergistic treatment of pulmonary fibrosis
Chen, Z., Yang, J., Zhang, Q., Zeng, W., Liu, Y., Hu, W., Chen, L., Shen, J., Miao, Y., Xiao, Z., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv9571 · Cited by 34
Extracellular signal-regulated kinase signaling pathway and silicosis
Xie, Y. G., Ma, J., Yang, M., Fan, L., & Chen, W. (2021) · Toxicology Research · doi:10.1093/toxres/tfaa109 · Cited by 31
Deleterious Role of Th9 Cells in Pulmonary Fibrosis
Deng, K., Yang, X. S., Luo, Q., She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cells · doi:10.3390/cells10113209 · Cited by 33
Chen, X., Wang, Z., Han, S., Wang, Z., Zhang, Y., Li, X., Xia, N. L., Yu, W., Jia, C., Ni, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04403-2 · Cited by 31
Huang, G., Liang, J., Huang, K. Y., Liu, X., Taghavifar, F., Yao, C., Parimon, T., Liu, N., Dai, K., Aziz, A. W., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0074oc · Cited by 31
Self-citationIL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis
Milara, J., Roger, I., Montero, P., Artigues, E., Escrivá, J., & Cortijo, J. (2022) · Respiratory Research · doi:10.1186/s12931-022-02241-0 · Cited by 31
Wang, Y., Wu, G., Yue, H., Zhou, Q. T., Zhang, L., He, L., Gu, W., Gao, R., Dong, L., Zhang, H., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.017 · Cited by 30
Ng, B., Viswanathan, S., Widjaja, A. A., Lim, W., Shekeran, S. G., Goh, J. W. T., Tan, J., Kuthubudeen, F. F., Lim, S. Y., Xie, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073549 · Cited by 30
Self-citationBachmann, J. C., Baumgart, S. J., Uryga, A., Bosteen, M. H., Borghetti, G., Nyberg, M., & Herum, K. M. (2022) · Cells · doi:10.3390/cells11101657 · Cited by 31
Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer
Leung, J. H., Ng, B., & Lim, W. (2022) · Cells · doi:10.3390/cells11142257 · Cited by 30
Self-citationInterleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target
O’Reilly, S. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad108 · Cited by 30
Metadata
- Authors
- Ng, B., Dong, J., D’Agostino, G., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Ko, N. S. J., Tan, J., Chothani, S. P., Huang, B., Xie, C., Pua, C. J., Chacko, A.-M., Guimarães-Camboa, N., Evans, S. M., Byrne, A. J., Maher, T. M., Liang, J., Jiang, D., Noble, P. W., Schafer, S., & Cook, S. A.
- Affiliations
- National University of Singapore (SG)
- National Heart Centre Singapore (SG)
- Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Frankfurt 60590, Germany.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
- Imperial College London (GB)
- Royal Brompton Hospital (GB)
- Cedars-Sinai Medical Center (US)
- National Heart Centre Singapore, 169609 Singapore, Singapore.
- Corresponding author
- Ng, Benjamin
- Dong, Jinrui
- D’Agostino, Giuseppe
- Cook, Stuart A.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2019-09-25
- Volume
- 11
- Issue
- 511
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2975410560
- Semantic Scholar
- 707edf16b55c02f433b992ddc906064a1c8f30f7
- Cited by
- 314
- References
- 92
- Citations by year
- 2026: 41 · 2025: 42 · 2024: 51 · 2023: 45 · 2022: 45 · 2021: 55 · 2020: 29 · 2019: 6
- FWCI
- 24.67
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nd
- Locations
- Science Translational Medicine (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
- PubMed (publishedVersion)
- Funders
- National Medical Research Council (NMRC) Singapore (NMRC/OFYIRG/0053/2017)
- NIHR Clinician Scientist Fellowship (HIHR Ref: CS-2013-13-017)
- British Lung Foundation Chair in Respiratory Research (C17-3)
- the National Medical Research Council (NMRC) Singapore STaR awards (NMRC/STaR/0011/2012)
- National Medical Research Council (NMRC) Singapore STaR awards (NMRC/STaR/0029/2017)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- interleukin-11, idiopathic pulmonary fibrosis, pulmonary fibrosis, lung fibroblast activation, myofibroblast activation, bleomycin-induced fibrosis, ERK signaling, Smad signaling, lung inflammation, therapeutic target
- MeSH terms
- Animals, Bleomycin, Fibroblasts, Humans, Lung, Severity of Illness Index, Signal Transduction, Up-Regulation, Interleukin-11, Mice, Knockout, Interleukin-11 Receptor alpha Subunit, Idiopathic Pulmonary Fibrosis, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review